## Abstract ## BACKGROUND: Magnetic resonance imaging (MRI) has been used to supplement screening mammography and clinical breast examination (CBE) in women who are at high risk of developing breast cancer. In this study, the authors investigated the efficacy of alternating screening mammography a
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging
β Scribed by Constance D. Lehman; Jeffrey D. Blume; Paul Weatherall; David Thickman; Nola Hylton; Ellen Warner; Etta Pisano; Stuart J. Schnitt; Constantine Gatsonis; Mitchell Schnall; for the International Breast MRI Consortium Working Group
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 112 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND
The authors compared the performance of screening mammography versus magnetic resonance imaging (MRI) in women at genetically high risk for breast cancer.
METHODS
The authors conducted an international prospective study of screening mammography and MRI in asymptomatic, genetically highβrisk women age β₯ 25 years. Women with a history of breast cancer were eligible for a contralateral screening if they had been diagnosed within 5 years or a bilateral screening if they had been diagnosed > 5 years previously. All examinations (MRI, mammography, and clinical breast examination [CBE]) were performed within 90 days of each other.
RESULTS
In total, 390 eligible women were enrolled by 13 sites, and 367 women completed all study examinations. Imaging evaluations recommended 38 biopsies, and 27 biopsies were performed, resulting in 4 cancers diagnosed for an overall 1.1% cancer yield (95% confidence interval [95%CI], 0.3β2.8%). MRI detected all four cancers, whereas mammography detected one cancer. The diagnostic yield of mammography was 0.3% (95%CI, 0.01β1.5%). The yield of cancer by MRI alone was 0.8% (95%CI, β 0.3β2.0%). The biopsy recommendation rates for MRI and mammography were 8.5% (95%CI, 5.8β11.8%) and 2.2% (95%CI, 0.1β4.3%).
CONCLUSIONS
Screening MRI in highβrisk women was capable of detecting mammographically and clinically occult breast cancer. Screening MRI resulted in 22 of 367 of women (6%) who had negative mammogram and negative CBE examinations undergoing biopsy, resulting in 3 additional cancers detected. MRI also resulted in 19 (5%) falseβpositive outcomes, which resulted in benign biopsies. Cancer 2005. Β© 2005 American Cancer Society.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Intensive screening is an alternative to prophylactic mastectomy in women at high risk for developing breast carcinoma. The current article reports preliminary results from a screening protocol using highβquality magnetic resonance imaging (MRI), ductal lavage (DL), clini
## Abstract ## BACKGROUND The purpose of the current study was to determine the frequency of βprobably benignβ interpretations at breast magnetic resonance (MR) imaging screening of highβrisk women and the frequency of subsequent malignancy in these women. ## METHODS The authors performed a retr
In the past five years the advent of cancer genetic testing has created concern about the negative psychosocial sequelae of genetic counseling and testing. Research indicates that the women most likely to seek genetic testing are anxious about carrying a gene mutation and developing breast cancer. W
## Abstract ## BACKGROUND. The American Cancer Society (ACS) guidelines for screening with breast magnetic resonance imaging (MRI) recommend MRI for women who have a lifetime risk β₯20% of developing breast cancer. Genetic testing for breast cancer gene (__BRCA__) mutations is offered to women who